Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-CRIP2 Antibody (5S293)
😃Good
Catalog No. TMAY-02739
Alias ESP1, cysteine-rich protein 2, CRP2, CRIP
Anti-CRIP2 Antibody (5S293) is a Mouse antibody targeting CRIP2. Anti-CRIP2 Antibody (5S293) can be used in IHC-P.
Anti-CRIP2 Antibody (5S293)
Anti-CRIP2 Antibody (5S293)
😃Good
Catalog No. TMAY-02739Alias ESP1, cysteine-rich protein 2, CRP2, CRIP
Anti-CRIP2 Antibody (5S293) is a Mouse antibody targeting CRIP2. Anti-CRIP2 Antibody (5S293) can be used in IHC-P.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 μL | $199 | 7-10 days | 7-10 days |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-CRIP2 Antibody (5S293) is a Mouse antibody targeting CRIP2. Anti-CRIP2 Antibody (5S293) can be used in IHC-P. |
| Synonyms | ESP1, cysteine-rich protein 2, CRP2, CRIP |
| Ig Type | Mouse IgG1 |
| Clone | 5S293 |
| Reactivity | Human |
| Specificity | Human CRIP2 |
| Verified Activity | Immunochemical staining of human CRIP2 in human placenta with mouse monoclonal antibody (1:100, formalin-fixed paraffin embedded sections). |
| Application | |
| Recommended Dose | IHC-P: 1:50-1:200 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CRIP2 (rh CRIP2; TMPY-03342; P52943; Met1-Pro208). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | CRIP2 is a putative transcription factor. It has a widespread tissue expression and is highly expressed in heart. CRIP2 contains two LIM zinc-binding domains. CRIP2 may participate in the differentiation of smooth muscle tissue. It also plays an important role in esophageal squamous cell carcinoma (ESCC) tumorigenesis. CRIP2 acts as a transcription repressor of the NF-κB-mediated proangiogenic cytokine expression and thus functionally inhibits tumor formation and angiogenesis. It interacts with the NF-κB/p65 to inhibit its DNA-binding ability to the promoter regions of the major proangiogenesis cytokines critical for tumor progression, including IL6, IL8, and VEGF. In conclusion, we provide compelling evidence that CRIP2 acts as a transcription repressor of the NF-κB-mediated proangiogenic cytokine expression and thus functionally inhibits tumor formation and angiogenesis. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human CRIP2 protein (TMPY-03342) |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-CRIP2 Antibody (5S293) | purchase Anti-CRIP2 Antibody (5S293) | Anti-CRIP2 Antibody (5S293) cost | order Anti-CRIP2 Antibody (5S293)
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.